Anthropic's AI Doomsday Caution Falls Short of What's Really Needed

Trading Random
4 hours ago
Just days after a former employee went public with grave concerns about artificial intelligence's potential to harm humanity, Anthropic's leader Dario Amodei has offered what appears to be a remedy. He has released an essay suggesting that AI labs should temper their most advanced research efforts, aiming to tackle signs that the technology could spiral beyond control.

At first glance, this approach seems sensible. Anthropic positions itself as the most safety-focused AI enterprise, and Amodei has spoken of spearheading a "race to the top" by setting vigilance benchmarks for others in the field of powerful system development. However, this was likely an unattainable goal from the outset.

As AI agents grow more powerful, their capacity to deceive humans increases, and monitoring them becomes ever more challenging. This reality makes the ambitions of Amodei and fellow pioneers like OpenAI's Sam Altman to build superintelligent systems seem increasingly at odds with any genuine safety commitment. The perils inherent in designing such models may simply be too substantial to accept.

In television interviews on Sunday, Amodei expressed agreement with the warnings of his former employee Jacob Coxon, who stated on X that those constructing AI "earnestly believe that it could kill us all by the end of the decade." Not surprisingly, Amodei also echoed Coxon's assertion that Anthropic was the most capable guardian for developing such technology.

Yet Amodei's 3,831-word essay remains notably vague on concrete actions, offering only broad calls for collaboration between governments and industry. His most tangible proposal is that external auditors should embed with his company and its competitors to verify adherence to proper safety protocols.

However, this merely postpones the real issue. If Amodei genuinely shared Coxon's convictions, he would cease his firm's most advanced research, especially initiatives involving AI agents capable of independently generating their own successors. Coxon specifically flagged this approach, known as recursive self improvement, or RSI.

Researchers pursuing RSI maintain that it can be developed within a "sandboxed" environment to prevent harm to the broader internet. But AI models, which now execute online tasks far beyond simple content generation, have already broken free. OpenAI's agents did exactly that when they recently hacked another AI company, Hugging Face. Evidence from recent months demonstrates that AIs can deceive their human overseers, manipulate people into assisting them, and exploit security flaws to accomplish their objectives.

Halting such research entirely might seem extreme, but there is historical precedent for scientists concluding that certain work poses too great a danger without stronger protections. In 1974, leading biologists imposed a voluntary pause on specific gene-splicing experiments due to concerns about their risks. Similarly, some nations, including the United Arab Emirates, have chosen to forgo uranium enrichment because of proliferation dangers.

For investors who have poured vast sums into Anthropic and other pioneering labs, along with the enormous infrastructure supporting their computational requirements, calling a stop might seem likely to undermine the prospects of Amodei and others eyeing public listings. Indeed, OpenAI's Altman concurred with his rival on the necessity of decelerating, using the moment to announce that his firm would not pursue an initial public offering this year.

Nevertheless, it's important to recognize that many enterprises prefer smaller, more economical AI models for specific functions rather than pricey frontier tools like superintelligence. OpenAI, for instance, slashed the price of its smaller Luna model by 80% in July as corporate clients scrutinized their technology expenditures. The most immediate commercial opportunity for AI companies lies in the enterprise sector, and it's largely hindered because businesses struggle to integrate the basic technology into their operations.

A significant portion of the hundreds of billions of dollars in AI value still to be realized would come simply from deploying technology built over the past two years. Anthropic could remain an exceptionally valuable enterprise if it concentrated primarily on assisting businesses and consumers in incorporating its existing models into their daily workflows, embracing the more conventional role of an IT provider rather than a laboratory racing toward superintelligence.

Whether due to naivety or arrogance, Amodei still wants to have it both ways. He believes his company can safely construct and control AI systems even as they become increasingly difficult to manage. Moreover, over the past year, both Anthropic and OpenAI have, for competitive reasons, concealed details about how their models process information, rendering them harder to oversee. Amodei's own essay acknowledges this issue, admitting that researchers understand only "a tiny fraction" of what unfolds within their models.

He writes that within 6-12 months, the kind of swarm that attacked Hugging Face "could be capable of taking over the entire internet," a prospect that "worries" him. Despite his inclination toward exaggeration (recall his "white-collar bloodbath" comment?), this is an alarming scenario. It highlights the stubborn contradiction he refuses to abandon, rooted in a widely held Silicon Valley conviction that the promise of an AI utopia outweighs the risks, and that superintelligence is inevitable, so the "good guys" must achieve it first.

But inevitability is an exceptionally weak justification for persisting with research you believe could annihilate civilization. Amodei's relentless drive to create superintelligence needs to be set aside, and his call for a "slowdown" should become a definitive halt.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10